Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Roche”

Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCCRecruiting
NCT05971108NAUpdated Sep 24, 2025
Sponsor: Manchester University NHS Foundation Trust
Liver Cirrhosis · Hepatocellular Carcinoma
United Kingdom
Correction of Anaemia and Progression of Renal Failure on Transplanted PatientsCompleted
NCT00396435Phase 4Updated Sep 23, 2025
Sponsor: Centre Hospitalier Universitaire, Amiens
Anaemia · Renal Transplantation · Kidney Failure
France
TACrolimus in Renal Transplantation: Individualization by PharmacogeneticCompleted
NCT00552201Phase 4Updated Sep 23, 2025
Sponsor: Centre Hospitalier Universitaire, Amiens
Kidney Transplantation
France
A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated GliomasActive Not Recruiting
NCT04808245Phase 1Updated Sep 22, 2025
Sponsor: German Cancer Research Center
Newly Diagnosed H3-mutated Glioma
Germany
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible SensitivityRecruiting
NCT04273061Phase 2Updated Sep 22, 2025
Sponsor: British Columbia Cancer Agency
Breast Cancer · Lung Cancer · Gastrointestinal Cancer · Genitourinary Cancer
Canada
A Study of Atezolizumab (Tecentriq) in Combination With Bevacizumab to Investigate Safety and Efficacy in Patients With Unresectable Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy-AmethistaCompleted
NCT04487067Phase 3Updated Sep 22, 2025
Sponsor: Hoffmann-La Roche
Carcinoma, Hepatocellular
Italy
Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 StudyActive Not Recruiting
NCT03820063Phase 2Updated Sep 19, 2025
Sponsor: Borstkanker Onderzoek Groep
Breast Cancer
Netherlands
A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis BCompleted
NCT04225715Phase 2Updated Sep 19, 2025
Sponsor: Hoffmann-La Roche
Hepatitis B, Chronic
Bulgaria, Canada, Chile, China, France +8 more
A Study Evaluating Efficacy and Safety of Multiple Treatment Combinations in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Morpheus-Head and Neck Cancer)Completed
NCT05459129Phase 1, Phase 2Updated Sep 15, 2025
Sponsor: Hoffmann-La Roche
Squamous Cell Carcinoma of the Head and Neck
United States, Israel, South Korea
A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis From France Who Completed WA19977 Core StudyCompleted
NCT01673919Phase 3Updated Sep 12, 2025
Sponsor: Hoffmann-La Roche
Juvenile Idiopathic Arthritis
France
A Study of Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Predialysis Patients Not Treated With ESA.Completed
NCT00661388Phase 3Updated Sep 11, 2025
Sponsor: Hoffmann-La Roche
Anemia
Turkey (Türkiye)
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.Completed
NCT00560404Phase 3Updated Sep 11, 2025
Sponsor: Hoffmann-La Roche
Anemia
Brazil
An Observational Study on RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (TRUST)Completed
NCT01394276N/AUpdated Sep 11, 2025
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Italy
A Study of MIRCERA in Participants With Chronic Kidney Disease Stage 3-4 and Not on DialysisCompleted
NCT02567188N/AUpdated Sep 11, 2025
Sponsor: Hoffmann-La Roche
Anemia
Sweden
Evaluation of the Impact of Multiple Sclerosis and Its Treatments on Women FertilityCompleted
NCT07164924N/AUpdated Sep 10, 2025
Sponsor: University Hospital, Clermont-Ferrand
Multiple Sclerosis · Neuromyelitis Optica Spectrum Disorders · Fertility
France, Martinique
Combination of Talimogene Laherparepvec With Atezolizumab in Early Breast CancerCompleted
NCT03802604EARLY_Phase 1Updated Sep 9, 2025
Sponsor: SOLTI Breast Cancer Research Group
Breast Cancer
Spain
Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast CancerActive Not Recruiting
NCT04759248Phase 2Updated Sep 9, 2025
Sponsor: SOLTI Breast Cancer Research Group
Breast Cancer
Spain
Patients With ES-SCLC and ECOG PS=2 Receiving Atezolizumab-Carboplatin-EtoposideCompleted
NCT04221529Phase 2Updated Sep 8, 2025
Sponsor: AIO-Studien-gGmbH
SCLC, Extensive Stage
Austria, Germany
A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.Active Not Recruiting
NCT04671693NAUpdated Sep 5, 2025
Sponsor: Centre Leon Berard
Late Effects · Testicular Germ Cell Tumor Mixed · Non-Metastatic Breast Carcinoma · Soft Tissue Sarcoma, Adult, Stage IIC
France
Interest of a Standardized Monitoring of Rheumatoid Arthritis: The COMEDRA TrialCompleted
NCT01315652NAUpdated Sep 5, 2025
Sponsor: Assistance Publique - Hôpitaux de Paris
Rheumatoid Arthritis
France
ABC-Scores for Reduction of Stroke and Mortality in Atrial Fibrillation - The ABC-AF StudyActive Not Recruiting
NCT03753490NAUpdated Sep 3, 2025
Sponsor: Uppsala University
Atrial Fibrillation
Sweden
A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic TherapyNot Yet Recruiting
NCT06680258Phase 3Updated Sep 3, 2025
Sponsor: Tempest Therapeutics
Hepatocellular Carcinoma (HCC)
A Single-Ascending-Dose Study of RO5469754 in Healthy VolunteersCompleted
NCT01620931Phase 1Updated Aug 28, 2025
Sponsor: Hoffmann-La Roche
Healthy Volunteer
Netherlands
Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper LimbActive Not Recruiting
NCT06300996NAUpdated Aug 26, 2025
Sponsor: Marco Capogrosso
Spinal Muscular Atrophy · Spinal Muscular Atrophy Type 3 · Spinal Muscular Atrophy Type II · Spinal Muscular Atrophy 4
United States
A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Crovalimab for the Management of Acute Uncomplicated Vaso-Occlusive Episodes (VOE) in Participants With Sickle Cell Disease (SCD).Completed
NCT04912869Phase 1Updated Aug 26, 2025
Sponsor: Hoffmann-La Roche
Sickle Cell Disease
United States, Brazil, France, Italy, Kenya +5 more

Previous page Next page